A detailed history of Farmers & Merchants Investments Inc transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Farmers & Merchants Investments Inc holds 8,861 shares of GILD stock, worth $780,476. This represents 0.02% of its overall portfolio holdings.

Number of Shares
8,861
Previous 8,661 2.31%
Holding current value
$780,476
Previous $594,000 24.92%
% of portfolio
0.02%
Previous 0.02%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024

BUY
$66.59 - $83.99 $13,318 - $16,798
200 Added 2.31%
8,861 $742,000
Q2 2024

Aug 05, 2024

BUY
$63.15 - $72.88 $12,251 - $14,138
194 Added 2.29%
8,661 $594,000
Q1 2024

Apr 18, 2024

SELL
$71.58 - $87.29 $1,789 - $2,182
-25 Reduced 0.29%
8,467 $620,000
Q4 2023

Jan 23, 2024

SELL
$73.27 - $83.09 $17,364 - $19,692
-237 Reduced 2.72%
8,492 $687,000
Q3 2023

Oct 25, 2023

SELL
$73.94 - $80.67 $517 - $564
-7 Reduced 0.08%
8,729 $654,000
Q2 2023

Aug 01, 2023

SELL
$76.01 - $86.7 $14,517 - $16,559
-191 Reduced 2.14%
8,736 $673,000
Q1 2023

May 12, 2023

SELL
$77.31 - $88.08 $3,092 - $3,523
-40 Reduced 0.45%
8,927 $740,000
Q4 2022

Feb 02, 2023

SELL
$62.32 - $89.47 $43,810 - $62,897
-703 Reduced 7.27%
8,967 $769,000
Q3 2022

Oct 31, 2022

BUY
$59.54 - $68.01 $13,694 - $15,642
230 Added 2.44%
9,670 $597,000
Q2 2022

Jul 28, 2022

SELL
$57.72 - $65.01 $43,405 - $48,887
-752 Reduced 7.38%
9,440 $583,000
Q1 2022

Apr 19, 2022

SELL
$57.92 - $72.58 $46,509 - $58,281
-803 Reduced 7.3%
10,192 $606,000
Q4 2021

Jan 14, 2022

BUY
$64.88 - $73.64 $19,139 - $21,723
295 Added 2.76%
10,995 $798,000
Q3 2021

Oct 21, 2021

BUY
$67.69 - $73.03 $454,876 - $490,761
6,720 Added 168.84%
10,700 $747,000
Q2 2020

Jul 21, 2020

SELL
$72.34 - $84.0 $21,991 - $25,536
-304 Reduced 7.1%
3,980 $306,000
Q1 2020

Apr 16, 2020

BUY
$62.63 - $80.22 $21,106 - $27,034
337 Added 8.54%
4,284 $320,000
Q4 2019

Jan 21, 2020

SELL
$61.62 - $67.78 $9,859 - $10,844
-160 Reduced 3.9%
3,947 $256,000
Q3 2019

Oct 18, 2019

BUY
$62.51 - $69.0 $625 - $690
10 Added 0.24%
4,107 $260,000
Q2 2019

Jul 24, 2019

BUY
$61.87 - $69.38 $2,598 - $2,913
42 Added 1.04%
4,097 $277,000
Q1 2019

Apr 26, 2019

BUY
$62.53 - $70.05 $4,001 - $4,483
64 Added 1.6%
4,055 $264,000
Q3 2018

Oct 30, 2018

SELL
$71.28 - $78.92 $314,059 - $347,721
-4,406 Reduced 52.47%
3,991 $308,000
Q2 2018

Jul 23, 2018

SELL
$64.88 - $75.68 $506,063 - $590,304
-7,800 Reduced 48.16%
8,397 $595,000
Q1 2018

Apr 17, 2018

BUY
$72.84 - $88.8 $30,082 - $36,674
413 Added 2.62%
16,197 $1.22 Million
Q4 2017

Jan 26, 2018

BUY
$71.15 - $83.52 $1,849 - $2,171
26 Added 0.16%
15,784 $1.13 Million
Q3 2017

Oct 19, 2017

BUY
$72.11 - $85.47 $1.14 Million - $1.35 Million
15,758
15,758 $1.28 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $110B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Farmers & Merchants Investments Inc Portfolio

Follow Farmers & Merchants Investments Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Farmers & Merchants Investments Inc, based on Form 13F filings with the SEC.

News

Stay updated on Farmers & Merchants Investments Inc with notifications on news.